檢索結果 - Bader-Meunier, B
- Showing 1 - 20 results of 33
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic J... 由 Ruperto, N, Quartier, P, Wulffraat, N, Woo, P, Loy, A, Mouy, R, Bader-Meunier, B, Prakken, B, Noseda, E, Rordorf, C
出版 2008Text -
19
-
20
Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients 由 Bader-Meunier, B, Hachulla, P, Kuemmerle-Deschner, J, Gattorno, M, Patel, N, Preiss, R, Lheritier, K, Imagawa, T, Nishikomori, R, Takada, H, Heike, T, Hara, T, Yokota, S
出版 2011Text